MassARRAY(TM) System Enables Detection of Fetal Genetic Mutations in Maternal Plasma
Technology has the Potential to Replace Widely Used Risky and Expensive Diagnostic Procedures
13-Jul-2004 -
San Diego. SEQUENOM, Inc. announced that through a collaboration with an international consortium led by The Chinese University of Hong Kong (CUHK) and Boston University (BU) a novel process to determine genetic mutations in circulating fetal nucleic acids in maternal plasma has been developed, ...
acids
bases
cystic fibrosis
+7